MapleLife TM Prostate Capsule
Natural health product licensed in Canada
- Other names
- North America Naturals Prostate Capsule, North America Naturals Prostate Revised formula, PROSTAVOID, Prostate One, Prostate Protect, Prostate Support, Royap Prostate Capsule, manMED Prostate Capsule, manMed Prostate Health
- Licence holder
- Nutralab Canada Corp.
- NPN or DIN-HM
- 80041852
- Status
- Active licence
- Licence date
- 22 April 2013
- Revision date
- 26 September 2025
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bêta-carotène Source : bêta-carotène | 0.5 milligramme | Not calculated |
| Panax quinquefolius Source : Racine Extract : Extract Type TBA Extraction ratio : 10:1 Dry plant equivalent : 500 mg | 50 milligramme | Not calculated |
| Extrait de pollen Source : Secale cereale - Anthère Extract : Extract Type TBA Extraction ratio : 2:1 Dry plant equivalent : 60 mg | 30 milligramme | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Hypromellose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 1 Capsule | 3 days |
Uses authorised in Canada
Used in Herbal Medicine to help relieve urologic symptoms associated with mild to moderate Benign Prostatic Hypeplasia (BPH). Help support general prostate health. Provide antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use to exclude a diagnosis of prostate cancer. If you are taking antidepressants, consult a health care practitioner prior to use. If you are taking blood thinners or digoxin, consult a health care practitioner prior to use. If you have high blood pressure, consult a health care practitioner prior to use. If you suffer from any psychological disorder and/or condition such as frequent anxiety or depression, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you have diabetes.
Source
Official Health Canada record, licence 80041852
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.